ANAPTYSBIO, INC
Ticker: 1370053
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 25.56-66.5% | 76.32+242.9% | 22.26-19.8% | 27.77-7.5% | 30.02+173.7% | 10.97+52.8% | 7.18+116.3% | 3.32 |
| Total Income | 25.56-66.5% | 76.32+242.9% | 22.26-19.8% | 27.77-7.5% | 30.02+173.7% | 10.97+52.8% | 7.18+116.3% | 3.32 |
| EXPENSES | ||||||||
| Expenditure | 60.19+44.6% | 41.62-14.1% | 48.43-12.4% | 55.31+4.8% | 52.77+2.9% | 51.29+3.9% | 49.38+20.3% | 41.05 |
| Tax | 0.04 | 0.00-100.0% | 0.04+0.0% | 0.04 | 0.00-100.0% | 0.01 | — | — |
| PROFIT | ||||||||
| PBT | -52.84-449.7% | 15.11+139.2% | -38.59+1.8% | -39.29-19.6% | -32.85+29.6% | -46.65 | — | — |
| Net Profit | -52.88-450.0% | 15.11+139.1% | -38.63+1.8% | -39.33-19.7% | -32.85+29.6% | -46.66-6.2% | -43.94-17.8% | -37.31 |
| KEY METRICS | ||||||||
| OPM % | -100.00%-145.47pp | 45.47%+145.47pp | -100.00%-0.83pp | -99.17%-23.35pp | -75.81%+24.19pp | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00%-119.80pp | 19.80%+119.80pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -1.84-440.7% | 0.54+140.3% | -1.34-4.7% | -1.28-12.3% | -1.14+33.3% | -1.71-4.3% | -1.64-16.3% | -1.41 |
Corporate Events
Board MeetingANAB
202611May
Board Meeting
CFO and Director Appointments — Christopher M. Murphy appoin…
SEC Filing ↗